Fusion Pharmaceuticals to Present at the TD Cowen Radiopharmaceutical Innovation Summit
HAMILTON, ON and BOSTON, June 16, 2023 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will present in a fireside chat at the…
Comments Off on Fusion Pharmaceuticals to Present at the TD Cowen Radiopharmaceutical Innovation Summit